Stock Analysis

Sichuan Gangtong Medical Equipment Group's (SZSE:301515) Shareholders Have More To Worry About Than Only Soft Earnings

Sichuan Gangtong Medical Equipment Group Co., Ltd's (SZSE:301515) recent weak earnings report didn't cause a big stock movement. We think that investors are worried about some weaknesses underlying the earnings.

See our latest analysis for Sichuan Gangtong Medical Equipment Group

earnings-and-revenue-history
SZSE:301515 Earnings and Revenue History October 30th 2024
Advertisement

The Impact Of Unusual Items On Profit

Importantly, our data indicates that Sichuan Gangtong Medical Equipment Group's profit received a boost of CN¥10.0m in unusual items, over the last year. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And that's as you'd expect, given these boosts are described as 'unusual'. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Sichuan Gangtong Medical Equipment Group.

Our Take On Sichuan Gangtong Medical Equipment Group's Profit Performance

Arguably, Sichuan Gangtong Medical Equipment Group's statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Sichuan Gangtong Medical Equipment Group's statutory profits are better than its underlying earnings power. In further bad news, its earnings per share decreased in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you want to do dive deeper into Sichuan Gangtong Medical Equipment Group, you'd also look into what risks it is currently facing. At Simply Wall St, we found 1 warning sign for Sichuan Gangtong Medical Equipment Group and we think they deserve your attention.

Today we've zoomed in on a single data point to better understand the nature of Sichuan Gangtong Medical Equipment Group's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SZSE:301515

Sichuan Gangtong Medical Equipment Group

Sichuan Gangtong Medical Equipment Group Co., Ltd.

Mediocre balance sheet and slightly overvalued.

Advertisement

Weekly Picks

AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25380.9% overvalued
70 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.4% undervalued
69 users have followed this narrative
10 users have commented on this narrative
20 users have liked this narrative
FU
FundamentallySarcastic
CCP logo
FundamentallySarcastic on Credit Corp Group ·

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Fair Value:AU$12.6411.0% overvalued
11 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Updated Narratives

BA
NVO logo
bactrian on Novo Nordisk ·

A Quality Compounder Marked Down on Overblown Fears

Fair Value:US$9542.0% undervalued
95 users have followed this narrative
8 users have commented on this narrative
0 users have liked this narrative
YI
ETSY logo
yiannisz on Etsy ·

Etsy Stock: Defending Differentiation in a World of Infinite Marketplaces

Fair Value:US$64.454.7% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ALGN logo
yiannisz on Align Technology ·

Align Technology Stock: Premium Orthodontics in a Cost-Sensitive World

Fair Value:US$154.623.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.4% undervalued
69 users have followed this narrative
10 users have commented on this narrative
20 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25380.9% overvalued
70 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0225.6% undervalued
1020 users have followed this narrative
6 users have commented on this narrative
28 users have liked this narrative